Lower Tumor Burden Patient with Progression after Sipuleucel-T, then Treated with Radium-223

Lower Tumor Burden Patient with Progression after Sipuleucel-T, then Radium-223 Given with Pain Relief Independent of PSA Response

Christopher Pieczonka, MD presents a case study of an mCRPC patient who achieved significant pain relief for a sustained period of time after treatment with radium-223, and whose pain was independent of the PSA.

Christopher Pieczonka, MD
Associated Medical Professionals of NY, PLLC

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe